A review of the role of steroid hormone receptors and hormonal dependence of renal cell carcinoma in certain patients is presented. The results of a cumulative series of estrogen, progesterone, and androgen receptor assays performed on 48 normal and malignant human renal tumor specimens are given. T
Hormone receptors in renal cell carcinoma
β Scribed by John Pearson; Michael A. Friedman; Philip G. Hoffman
- Publisher
- Springer
- Year
- 1981
- Tongue
- English
- Weight
- 309 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
β¦ Synopsis
We have performed 23 estrogen and 24 progesterone receptor assays on tumor specimens from 26 patients with renal cancer, ten of whom subsequently received hormonal therapy for metastatic disease. Only one of these specimens contained measurable estrogen receptor levels, three contained low, but measurable progesterone receptor levels, and the remaining specimens contained no measurable estrogen or progesterone receptors. None of ten patients with metastases showed evidence of an objective response to hormonal therapy. Our data suggest that few, if any, renal cancers have high titers of estrogen or progesterone receptors, and that those patients whose tumors have low receptor titers are unlikely to respond to hormonal therapy.
π SIMILAR VOLUMES
## Abstract Specific estrogen, progesterone and androgen receptors were determined in 19 wellβcharacterized squamousβcell carcinoma (SCC) cell lines. Ten of the lines were derived from patients with SCC of the larynx and nine were from patients with SCC originating in other areas of the head and ne
## Abstract Numerous peptide receptors are overexpressed in human cancer, permitting __in vivo__ tumor targeting. Among such receptors, those for the neurotransmitter neuropeptide Y (NPY) are overexpressed in various tumors. Since NPY can play a role in the kidney, NPY receptor expression and/or en